Literature DB >> 23183153

Research letter: is monitoring for CD4 counts still needed for the management of patients with long-term HIV RNA suppression?

Christoph Stephan, Andrew Hill, Ning Xi, Yvon van Delft, Christiane Moecklinghoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23183153     DOI： 10.1097/QAI.0b013e3182737254

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Authors:  Jin Young Ahn; David Boettiger; Matthew Law; Nagalingeswaran Kumarasamy; Evy Yunihastuti; Romanee Chaiwarith; Man Po Lee; Benedict L H Sim; Shinichi Oka; Wingwai Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Praphan Phanuphak; Oon Tek Ng; Sasisopin Kiertiburanakul; Fujie Zhang; Sanjay Pujari; Rossana Ditangco; Winai Ratanasuwan; Tuti Parwati Merati; Vonthanak Saphonn; Annette H Sohn; Jun Yong Choi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Authors:  Antonio Di Biagio; Marta Ameri; Davide Sirello; Giovanni Cenderello; Enrico Di Bella; Lucia Taramasso; Barbara Giannini; Mauro Giacomini; Claudio Viscoli; Giovanni Cassola; Marcello Montefiori
Journal:  BMC Infect Dis       Date:  2017-02-06       Impact factor: 3.090

Review 3.  CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Nathan Ford; Kathryn Stinson; Howard Gale; Edward J Mills; Wendy Stevens; Mercedes Pérez González; Mercedes P González; Jessica Markby; Andrew Hill
Journal:  J Int AIDS Soc       Date:  2015-08-07       Impact factor: 5.396

4.  Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio.

Authors:  Sergio Serrano-Villar; María Jesús Pérez-Elías; Fernando Dronda; José Luis Casado; Ana Moreno; Ana Royuela; José Antonio Pérez-Molina; Talia Sainz; Enrique Navas; José Manuel Hermida; Carmen Quereda; Santiago Moreno
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.